FOXA1 expression and survival outcomes in triple-negative breast cancer: A retrospective cohort study
Triple-negative breast cancer (TNBC) remains the most aggressive breast cancer subtype, with the poorest prognosis among all forms of breast cancer. FOXA1 is a well-known pioneer factor in luminal breast cancer, however, despite its vital role in this tumor subtype, detailed information about FOXA1 expression and funct...